The incidence of cryptococcosis is increasing with the global emergence of AIDS and this now represents a major life-threatening fungal infection in HIV-AIDS patients (1). Cryptococcal meningitis is a leading cause of death in AIDS patients and contributes substantially to the high early mortality in antiretroviral treatment (ART) programs in low-resource settings (1). Relatively high prevalence of cryptococcal infection has been reported in low-resource country like Nigeria (2). In more affluent countries, the incidence of HIV-associated cryptococcosis has decreased dramatically (3). Cryptococcal infections in HIV/AIDS patients contribute substantially to the high early mortality in antiretroviral treatment (ART) programs in low-resource countries (1).
Objective
Screening of a targeted group of HIV patients on antiretroviral therapy (ART) for early detection of cryptococcal infection.